HOWL Werewolf Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Lug 31, 2026
$0,93
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$0,27minimo 52 sett.
$2,15massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$45M
P/E
-0.7
EPS
$-1.33
i tuoi badge
Intervallo 52 sett.
$0–$2
Rating Analisti
BUY
Prezzo Obiettivo
$7
P/E
-0.7
ROE
-183.6%
Margine di Profitto Netto
·
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
HOWL Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$0.93
Capitalizzazione di Mercato (MRQ)
$45M
P/E
-0.7
EPS
$-1.33
ROE
-183.6%
D/E Debito/Patrimonio (MRQ)
0.0
Intervallo 52 sett.
$0–$2
HOWL Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Performance decennale Andamento di ricavi, utile netto, margini e EPS
EPS$-1.332020-12-31 → 2025-12-31
Flusso di cassa libero$-60M2021-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | HOWL | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | -0.7media 5 anni ≈-1.5 | ≈-1.5 | · | · | |
| P/B (MRQ) | 2.8media 5 anni ≈1.2 | ≈1.2 | 0.8 | Sopravvalutato | |
| EV / EBITDA | -0.3media 5 anni ≈-0.0 | ≈-0.0 | · | · | |
| Price / FCF (Prezzo / FCF) | -0.7media 5 anni ≈-3.0 | ≈-3.0 | · | · | |
| Price / Cash Flow (Prezzo / Flusso di cassa) | -0.7media 5 anni ≈-3.1 | ≈-3.1 | · | · | |
| EV / FCF | -0.3media 5 anni ≈0.0 | ≈0.0 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 1.8media 5 anni ≈1.2 | ≈1.2 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | HOWL | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| ROA | -62.0%media 5 anni ≈-39.8% | ≈-39.8% | -69.2% | In linea | |
| ROE | -183.6%media 5 anni ≈-75.4% | ≈-75.4% | -94.1% | Debole |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | HOWL | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto (MRQ) | 0.0media 5 anni ≈0.4 | ≈0.4 | · | · | |
| Rapporto corrente (MRQ) | 2.9media 5 anni ≈7.1 | ≈7.1 | 4.2 | Bassa liquidità | |
| Quick Ratio | 1.6media 5 anni ≈6.9 | ≈6.9 | 2.2 | Liquidità elevata |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
29.3%
Prossimo report
Nov 02, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | $0.08 | $-0.27 | 130.2% | |
| 31 Marzo 2026 | $-0.28 | $-0.29 | 3.7% | |
| 31 Dicembre 2025 | $-0.17 | $-0.35 | 51.7% | |
| 30 Settembre 2025 | $-0.36 | $-0.40 | 9.5% | |
| 30 Giugno 2025 | $-0.40 | $-0.49 | 17.6% | |
| 31 Marzo 2025 | $-0.40 | $-0.40 | 0.47% | |
| 31 Dicembre 2024 | $-0.46 | $-0.43 | -7.8% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $45M | $56M | $42M | $54M | $35M | $17M | |
| SG&A Expense | $16M | $19M | $19M | $19M | $15M | $6M | |
| Operating Expenses | $61M | $75M | $60M | $72M | $50M | $22M | |
| Operating Income | $-61M | $-74M | $-41M | $-56M | $-50M | $-22M | |
| Interest Expense | · | · | $3M | $0 | · | · | |
| Interest Income | $3M | $7M | $7M | $2M | · | · | |
| Other Non-op | $2M | $2M | $-1M | $338.0K | $104.0K | $7M | |
| Income Tax | $0 | · | · | · | · | · | |
| Net Income | $-61M | $-71M | $-37M | $-54M | $-50M | $-15M | |
| EPS (Basic) | $-1.32 | $-1.63 | $-1.05 | $-1.86 | $-10.94 | $-28.08 | |
| EPS (Diluted) | $-1.33 | $-1.63 | $-1.05 | $-1.86 | $-10.94 | $-28.08 | |
| Shares (Basic) | 46,018,888 | 43,332,088 | 35,646,572 | 28,863,935 | 18,455,000 | 1,005,000 | |
| Shares (Diluted) | 46,810,252 | 43,859,664 | 35,646,572 | 28,863,935 | 18,455,000 | 1,005,000 | |
| EBITDA | $-61M | $-74M | $-41M | $-56M | $-50M | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $57M | $111M | $134M | $129M | $158M | $93M | |
| Prepaid Expense | $2M | $2M | $3M | $4M | $4M | $344.0K | |
| Current Assets | $59M | $113M | $138M | $140M | $161M | $93M | |
| PP&E (Net) | $5M | $6M | $8M | $9M | $3M | $651.0K | |
| PP&E (Gross) | $11M | $11M | $11M | $10M | $3M | $826.0K | |
| Accum. Depreciation | · | · | · | · | $391.0K | · | |
| Other Non-current Assets | $5.0K | $320.0K | $594.0K | $1M | $649.0K | $0 | |
| Total Assets | $69M | $127M | $175M | $160M | $179M | $96M | |
| Accounts Payable | $754.0K | $3M | $1M | $1M | $2M | $1M | |
| Accrued Liabilities | $5M | $11M | $9M | $14M | $9M | $4M | |
| Short-term Debt | $28M | $0 | $7M | $0 | · | · | |
| Current Liabilities | $36M | $15M | $19M | $24M | $12M | $5M | |
| Capital Leases | $8M | $9M | $11M | $13M | $15M | $2M | |
| Other Non-current Liabilities | · | · | $0 | $191.0K | $0 | $31.0K | |
| Total Liabilities | $45M | $54M | $63M | $38M | $26M | $7M | |
| Long-term Debt | $32M | $32M | $40M | · | · | · | |
| Total Debt | $28M | $0 | $7M | · | · | · | |
| Common Stock | $5.0K | $5.0K | $4.0K | $3.0K | $2.0K | $2.0K | |
| Paid-in Capital | $500M | $488M | $455M | $429M | $406M | $0 | |
| Retained Earnings | $-475M | $-415M | $-344M | $-307M | $-253M | $-52M | |
| Stockholders' Equity | $25M | $73M | $111M | $122M | $153M | $-52M | |
| Liabilities + Equity | $69M | $127M | $175M | $160M | $179M | $96M | |
| Shares Outstanding | 48,596,817 | 44,827,159 | 39,107,048 | 31,515,074 | 27,313,000 | 1,184,000 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $9M | $8M | $7M | $4M | $632.0K | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Operating Cash Flow | $-60M | $-56M | $-33M | $-41M | $-43M | $-19M | |
| CapEx | $0 | $254.0K | $769.0K | $4M | $498.0K | $560.0K | |
| Investing Cash Flow | $0 | $-254.0K | $-769.0K | $-4M | $-498.0K | $-560.0K | |
| Stock Issued | $6M | $24M | $18M | $16M | $0 | · | |
| Net Stock Activity | $6M | $24M | $18M | $16M | · | · | |
| Financing Cash Flow | $6M | $13M | $58M | $16M | $109M | $94M | |
| Net Change in Cash | $-54M | $-43M | $25M | $-28M | $66M | $75M | |
| Free Cash Flow | $-60M | $-56M | $-33M | $-44M | $-43M | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -62.0% | -46.7% | -22.3% | -31.7% | -36.3% | · | |
| ROE | -183.6% | -86.6% | -33.4% | -42.5% | -31.0% | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 7.4 | 7.1 | 5.8 | 13.6 | · | |
| Quick Ratio | 1.6 | 7.3 | 6.9 | 5.4 | 13.3 | · | |
| Debt / Equity | 1.1 | 0.0 | 0.1 | · | · | · | |
| Interest Coverage | · | · | -12.9 | · | · | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.51 | $1.64 | $2.85 | $3.89 | $5.59 | · | |
| Cash Flow / Share | $-1.29 | $-1.28 | $-0.91 | $-1.41 | $-2.32 | · | |
| Cash / Share | $1.17 | $2.48 | $3.44 | $4.11 | $5.77 | · | |
| EPS (TTM) | $-1.33 | $-1.63 | $-1.05 | $-1.86 | $-10.94 | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-61M | $-71M | $-37M | $-54M | $-50M | · | |
| Market Cap | $31M | $66M | $151M | $64M | $325M | · | |
| Enterprise Value | $2M | $-45M | $23M | · | · | · | |
| P/E | -0.5 | -0.9 | -3.7 | -1.1 | -1.1 | · | |
| P/B | 1.2 | 0.9 | 1.4 | 0.5 | 2.1 | · | |
| P / Tangible Book | 1.2 | 0.9 | 1.4 | 0.5 | 2.1 | · | |
| P / Cash Flow | -0.5 | -1.2 | -4.6 | -1.6 | -7.6 | · | |
| P / FCF | -0.5 | -1.2 | -4.5 | -1.5 | -7.5 | · | |
| EV / EBITDA | -0.0 | 0.6 | -0.6 | · | · | · | |
| EV / FCF | -0.0 | 0.8 | -0.7 | · | · | · | |
| Earnings Yield | -209.8% | -110.1% | -27.2% | -90.7% | -91.9% | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $6M | $8M | $7M | $12M | $13M | $13M | $16M | $13M | $15M | $13M | $10M | $11M | $10M | $12M | $16M | $13M | |
| SG&A Expense | $8M | $5M | $2M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $5M | $5M | $5M | $4M | |
| Operating Expenses | $14M | $13M | $9M | $16M | $18M | $18M | $20M | $17M | $20M | $18M | $14M | $15M | $14M | $17M | $20M | $18M | |
| Operating Income | $7M | $-13M | $-9M | $-16M | $-18M | $-18M | $-20M | $-17M | $-19M | $-17M | $-13M | $-9M | $-6M | $-12M | $-13M | $-13M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1M | · | · | · | $172.0K | · | · | |
| Interest Income | $277.0K | $433.0K | $564.0K | $697.0K | $850.0K | $997.0K | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | |
| Other Non-op | $64.0K | $674.0K | $2M | $0 | $11.0K | $168.0K | $-94.0K | $97.0K | $2M | $-1.0K | $-6.0K | $-5.0K | $-25.0K | $-1M | $70.0K | $3.0K | |
| Net Income | $4M | $-14M | $-8M | $-16M | $-18M | $-18M | $-20M | $-17M | $-17M | $-16M | $-12M | $-8M | $-5M | $-12M | $-12M | $-12M | |
| EPS (Basic) | $0.08 | $-0.28 | $-0.16 | $-0.36 | $-0.40 | $-0.40 | $-0.46 | $-0.38 | $-0.40 | $-0.39 | $-0.34 | $-0.23 | $-0.14 | $-0.34 | $-0.37 | $-0.40 | |
| EPS (Diluted) | $0.08 | $-0.28 | $-0.17 | $-0.36 | $-0.40 | $-0.40 | $-0.43 | $-0.38 | $-0.43 | $-0.39 | $-0.34 | $-0.23 | $-0.14 | $-0.34 | $-0.37 | $-0.40 | |
| Shares (Basic) | 48,597,534 | 48,596,817 | · | 45,804,042 | 44,981,746 | 44,827,159 | · | 43,704,836 | 43,521,406 | 41,607,279 | · | 35,653,924 | 35,557,701 | 34,784,682 | · | 29,764,000 | |
| Shares (Diluted) | 48,597,534 | 49,388,181 | · | 45,804,042 | 44,981,746 | 44,827,159 | · | 43,704,836 | 44,043,184 | 41,607,279 | · | 35,653,924 | 35,557,701 | 34,784,682 | · | 29,764,000 | |
| EBITDA | $7M | $-13M | · | $-16M | $-18M | $-18M | · | $-17M | $-19M | $-17M | · | $-9M | $-6M | $-12M | · | $-13M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $22M | $46M | $57M | $66M | $78M | $92M | $111M | $123M | $135M | $139M | $134M | $130M | $137M | $148M | $129M | $140M | |
| Prepaid Expense | $905.0K | $2M | $2M | $2M | $3M | $2M | $2M | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $4M | $7M | |
| Current Assets | $23M | $49M | $59M | $68M | $80M | $94M | $113M | $126M | $139M | $142M | $138M | $139M | $147M | $157M | $140M | $152M | |
| PP&E (Net) | $1M | $4M | $5M | $5M | $5M | $6M | $6M | $7M | $7M | $8M | $8M | $8M | $8M | $9M | $9M | $9M | |
| PP&E (Gross) | · | · | $11M | · | · | · | $11M | · | · | · | $11M | · | · | · | $10M | $10M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $992.0K | |
| Other Non-current Assets | $0 | $0 | $5.0K | $46.0K | $122.0K | $179.0K | $320.0K | $42.0K | $265.0K | $248.0K | $594.0K | $516.0K | $652.0K | $670.0K | $1M | $2M | |
| Total Assets | $24M | $58M | $69M | $80M | $93M | $107M | $127M | $140M | $154M | $178M | $175M | $176M | $185M | $195M | $160M | $172M | |
| Accounts Payable | $2M | $4M | $754.0K | $1M | $3M | $986.0K | $3M | $1M | $1M | $2M | $1M | $1M | $1M | $2M | $1M | $1M | |
| Accrued Liabilities | $6M | $5M | $5M | $9M | $9M | $9M | $11M | $10M | $9M | $6M | $9M | $8M | $10M | $13M | $14M | $14M | |
| Short-term Debt | $0 | $29M | $28M | $6M | $2M | · | $0 | $0 | $0 | $12M | $7M | $2M | · | · | $0 | · | |
| Current Liabilities | $8M | $39M | $36M | $18M | $15M | $12M | $15M | $12M | $11M | $21M | $19M | $14M | $15M | $22M | $24M | $28M | |
| Capital Leases | $0 | $7M | $8M | $8M | $9M | $9M | $9M | $10M | $10M | $11M | $11M | $11M | $12M | $12M | $13M | $13M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $191.0K | $191.0K | |
| Total Liabilities | $8M | $46M | $45M | $50M | $51M | $50M | $54M | $51M | $50M | $60M | $63M | $64M | $67M | $74M | $38M | $41M | |
| Long-term Debt | · | $32M | $32M | $32M | $32M | $32M | · | $32M | $32M | $40M | · | · | · | · | · | · | |
| Total Debt | $0 | $29M | · | $6M | $2M | · | · | $0 | $0 | $12M | · | $2M | · | · | · | · | |
| Common Stock | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $502M | $501M | $500M | $497M | $492M | $490M | $488M | $484M | $482M | $478M | $455M | $445M | $442M | $440M | $429M | $426M | |
| Retained Earnings | $-485M | $-489M | $-475M | $-467M | $-451M | $-433M | $-415M | $-394M | $-378M | $-360M | $-344M | $-332M | $-324M | $-319M | $-307M | $-295M | |
| Stockholders' Equity | $16M | $12M | $25M | $30M | $41M | $57M | $73M | $89M | $104M | $118M | $111M | $112M | $119M | $121M | $122M | $131M | |
| Liabilities + Equity | $24M | $58M | $69M | $80M | $93M | $107M | $127M | $140M | $154M | $178M | $175M | $176M | $185M | $195M | $160M | $172M | |
| Shares Outstanding | 48,599,066 | 48,596,817 | 48,596,817 | 47,273,685 | 45,335,265 | 44,827,159 | 44,827,159 | 43,721,772 | 43,702,147 | 43,282,371 | 39,107,048 | 35,658,000 | 35,642,000 | 35,301,000 | 31,433,731 | 30,611,000 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $419.0K | $929.0K | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $7M | $-11M | $-11M | $-15M | $-15M | $-19M | $-14M | $-12M | $-14M | $-15M | $-5M | $-7M | $-11M | $-10M | $-12M | $-14M | |
| CapEx | · | · | $0 | $0 | $0 | $0 | $123.0K | $3.0K | $17.0K | $111.0K | $198.0K | $221.0K | $182.0K | $168.0K | $518.0K | $2M | |
| Investing Cash Flow | · | · | $0 | $0 | $0 | $0 | $-123.0K | $-3.0K | $-17.0K | $-111.0K | $-198.0K | $-221.0K | $-182.0K | $-168.0K | $-518.0K | $-2M | |
| Stock Issued | · | · | $2M | $3M | $347.0K | $0 | $2M | $-29.0K | $877.0K | $20M | $9M | $-84.0K | $552.0K | $9M | $979.0K | $11M | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $20M | · | · | · | $9M | · | · | |
| Financing Cash Flow | · | · | $2M | $3M | $388.0K | $0 | $3M | $-6.0K | $-10M | $20M | $9M | $41.0K | $692.0K | $49M | $1M | $11M | |
| Net Change in Cash | $-25M | $-11M | $-9M | $-12M | $-15M | $-19M | $-12M | $-12M | $-24M | $5M | $4M | $-7M | $-10M | $39M | $-11M | $-5M | |
| Free Cash Flow | · | · | · | · | · | $-19M | · | · | · | $-15M | · | · | · | $-10M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | 6.3% | -16.4% | · | -14.9% | -14.6% | -12.7% | · | -10.5% | -10.2% | -8.7% | · | -4.8% | -2.8% | -6.7% | · | -6.8% | |
| ROE | 12.7% | -38.9% | · | -27.5% | -24.7% | -20.7% | · | -16.5% | -15.5% | -13.6% | · | -6.8% | -4.1% | -9.2% | · | -8.0% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | 1.3 | · | 3.9 | 5.3 | 8.1 | · | 10.1 | 12.1 | 6.7 | · | 9.6 | 9.8 | 7.2 | · | 5.5 | |
| Quick Ratio | 2.8 | 1.2 | · | 3.7 | 5.1 | 7.9 | · | 9.9 | 11.8 | 6.6 | · | 9.0 | 9.2 | 6.8 | · | 5.1 | |
| Debt / Equity | 0.0 | 2.4 | · | 0.2 | 0.1 | · | · | 0.0 | 0.0 | 0.1 | · | 0.0 | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -17.1 | · | · | · | · | · | · |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.34 | $0.25 | · | $0.63 | $0.91 | $1.28 | · | $2.04 | $2.38 | $2.72 | · | $3.15 | $3.33 | $3.43 | · | $4.28 | |
| Cash Flow / Share | · | $-0.21 | · | · | · | $-0.42 | · | · | · | $-0.37 | · | · | · | $-0.28 | · | · | |
| Cash / Share | $0.45 | $0.96 | · | $1.39 | $1.71 | $2.05 | · | $2.81 | $3.10 | $3.22 | · | $3.65 | $3.86 | $4.19 | · | $4.59 | |
| EPS (TTM) | $-0.73 | $-1.21 | · | $-1.59 | $-1.61 | $-1.64 | · | $-1.54 | $-1.39 | $-1.10 | · | $-1.08 | $-1.25 | $-1.64 | · | $75.26 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-35M | $-56M | · | $-73M | $-73M | $-72M | · | $-62M | $-54M | $-42M | · | $-37M | $-41M | $-50M | · | $-60M | |
| Market Cap | $17M | $40M | · | $93M | $49M | $44M | · | $93M | $107M | $280M | · | $76M | $109M | $92M | · | $138M | |
| Enterprise Value | $-4M | $23M | · | $33M | $-26M | · | · | $-30M | $-29M | $153M | · | $-52M | · | · | · | · | |
| P/E | -0.5 | -0.7 | · | -1.2 | -0.7 | -0.6 | · | -1.4 | -1.8 | -5.9 | · | -2.0 | -2.4 | -1.6 | · | 0.1 | |
| P/B | 1.1 | 3.3 | · | 3.1 | 1.2 | 0.8 | · | 1.0 | 1.0 | 2.4 | · | 0.7 | 0.9 | 0.8 | · | 1.1 | |
| P / Tangible Book | 1.1 | 3.3 | · | 3.1 | 1.2 | 0.8 | · | 1.0 | 1.0 | 2.4 | · | 0.7 | 0.9 | 0.8 | · | 1.1 | |
| P / Cash Flow | · | -3.8 | · | · | · | -2.3 | · | · | · | -18.3 | · | · | · | -9.3 | · | · | |
| Earnings Yield | -202.8% | -145.3% | · | -80.7% | -147.7% | -168.7% | · | -72.6% | -57.0% | -17.0% | · | -50.5% | -41.0% | -63.1% | · | 1668.7% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Utile netto | $-61M | $-71M | $-37M | $-54M | $-50M |
| EPS Diluito | $-1.33 | $-1.63 | $-1.05 | $-1.86 | $-10.94 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | 1.1 | 0.0 | 0.1 | · | · |
| Rapporto corrente | 1.6 | 7.4 | 7.1 | 5.8 | 13.6 |
| Quick Ratio | 1.6 | 7.3 | 6.9 | 5.4 | 13.3 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-60M | $-56M | $-33M | $-44M | $-43M |
Proprietari istituzionali (13F) 53 filer · $13.4M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
53
Valore detenuto
$13.4M
Nuove posizioni
11
Posizioni chiuse
11
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 11 (+1 vs trimestre precedente) | 11 (0 vs trimestre precedente) | 9 (0 vs trimestre precedente) | 9 (-3 vs trimestre precedente) | -3.0M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | $8.490.424 | 4.309.860 | 63,19% | Azioni |
| VANGUARD GROUP INC | $892.702 | 1.408.047 | 6,64% | Azioni |
| RA CAPITAL MANAGEMENT, L.P. | $859.349 | 2.387.744 | 6,40% | Azioni |
| Balyasny Asset Management L.P. | $644.253 | 1.790.089 | 4,79% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $438.471 | 1.217.976 | 3,26% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $242.800 | 674.632 | 1,81% | Azioni |
| Lynx1 Capital Management LP | $236.737 | 657.786 | 1,76% | Azioni |
| SPHERA FUNDS MANAGEMENT LTD. | $225.589 | 626.810 | 1,68% | Azioni |
| DC Funds, LP | $212.018 | 589.102 | 1,58% | Azioni |
| Verdad Advisers, LP | $125.500 | 348.709 | 0,93% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $120.895 | 335.815 | 0,90% | Azioni |
| BANK OF AMERICA CORP /DE/ | $111.829 | 311.502 | 0,83% | Azioni |
| XTX Topco Ltd | $97.705 | 271.478 | 0,73% | Azioni |
| Cubist Systematic Strategies, LLC | $92.020 | 46.711 | 0,68% | Azioni |
| JANE STREET GROUP, LLC | $90.637 | 251.837 | 0,67% | Azioni |
| UBS Group AG | $77.702 | 215.838 | 0,58% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $56.781 | 157.726 | 0,42% | Azioni |
| STATE STREET CORP | $42.889 | 119.168 | 0,32% | Azioni |
| Squarepoint Ops LLC | $37.157 | 103.242 | 0,28% | Azioni |
| BlackRock, Inc. | $36.556 | 101.573 | 0,27% | Azioni |
| Rangeley Capital, LLC | $35.990 | 100.000 | 0,27% | Azioni |
| NORTHERN TRUST CORP | $31.258 | 86.851 | 0,23% | Azioni |
| Alyeska Investment Group, L.P. | $31.151 | 86.554 | 0,23% | Azioni |
| MPM BIOIMPACT LLC | $28.851 | 80.142 | 0,21% | Azioni |
| CITADEL ADVISORS LLC | $26.993 | 75.000 | 0,20% | Opzione Call |
| Point72 Asia (Singapore) Pte. Ltd. | $25.642 | 13.016 | 0,19% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $22.334 | 62.055 | 0,17% | Azioni |
| H D Vest Advisory Services | $11.118 | 10.200 | 0,08% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $9.825 | 27.300 | 0,07% | Azioni |
| StoneX Group Inc. | $9.000 | 20.000 | 0,07% | Azioni |
| GOLDMAN SACHS GROUP INC | $7.206 | 20.023 | 0,05% | Azioni |
| MORGAN STANLEY | $6.877 | 19.108 | 0,05% | Azioni |
| TWO SIGMA ADVISERS, LP | $6.525 | 10.300 | 0,05% | Azioni |
| CITADEL ADVISORS LLC | $5.578 | 15.500 | 0,04% | Opzione Put |
| CERTUITY, LLC | $5.399 | 15.000 | 0,04% | Azioni |
| HBK Sorce Advisory LLC | $5.317 | 13.227 | 0,04% | Azioni |
| BARCLAYS PLC | $4.763 | 13.235 | 0,04% | Azioni |
| Larson Financial Group LLC | $4.697 | 13.052 | 0,03% | Azioni |
| LPL Financial LLC | $4.244 | 11.791 | 0,03% | Azioni |
| Ranch Capital Advisors Inc. | $3.959 | 11.000 | 0,03% | Azioni |
| Marest Capital, LLC | $3.912 | 10.870 | 0,03% | Azioni |
| Cetera Investment Advisers | $3.671 | 10.200 | 0,03% | Azioni |
| Tower Research Capital LLC (TRC) | $3.562 | 9.897 | 0,03% | Azioni |
| OSAIC HOLDINGS, INC. | $3.105 | 8.625 | 0,02% | Azioni |
| Financial Perspectives, Inc | $2.429 | 6.750 | 0,02% | Azioni |
| GROUP ONE TRADING LLC | $673 | 1.871 | 0,01% | Azioni |
| JPMORGAN CHASE & CO | $650 | 2.108 | 0,00% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $284 | 790 | 0,00% | Azioni |
| SIMPLEX TRADING, LLC | $91 | 255 | 0,00% | Azioni |
| SBI Securities Co., Ltd. | $36 | 100 | 0,00% | Azioni |
Attivisti e proprietari del 5%+ 4 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×13 depositi | 02 Luglio 2026 | 4,10% | Modifica | · | SEC |
| MPM BioVentures 2014, L.P., MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, UBS Oncology Impact Fund L.P., MPM BioVentures 2014 GP LLC, MPM BioVentures 2014 LLC, Oncology Impact Fund (Cayman) Management L.P., MPM BioImpact LLC, ANSBERT GADICKE, LUKE EVNIN, Todd Foley, MPM ASSET MANAGEMENT LLC, MPM ONCOLOGY INNOVATIONS FUND LP, MPM Oncology Innovations Fund GP LLC ×8 depositi | 12 Maggio 2026 | 3,80% | Modifica | · | SEC |
| Taiho Ventures LLC | 13 Maggio 2021 | · | Deposito iniziale | Campagna per il consiglio di amministrazione | SEC |
| Arkin Bio Ventures 2 L.P., Arkin Bio Venture GPGP Ltd., Moshe Arkin, Alon Lazarus | 10 Maggio 2021 | · | Deposito iniziale | Campagna per il consiglio di amministrazione | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 20 insider · 6 dirigenti · 10 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Daniel J Hicklin | President and Chief Executive Officer | 02 Gennaio 2025 A | · | 0 | 0 | $0 |
| Timothy W. Trost | Chief Financial Officer | 02 Gennaio 2025 A | · | 0 | 0 | $0 |
| Chulani Karunatilake | Chief Technology Officer | 02 Gennaio 2025 A | · | 0 | 0 | $0 |
| Ellen Lubman | Chief Business Officer | 02 Gennaio 2025 A | · | 0 | 0 | $0 |
| Randi Isaacs | Chief Medical Officer | 02 Gennaio 2025 A | · | 0 | 0 | $0 |
| Cynthia Seidel-Dugan | Chief Scientific Officer | 02 Gennaio 2024 A | 164.888 | 0 | 0 | $0 |
| Luke Evnin | Direttore | 07 Luglio 2026 S | 0 | 0 | 87 | $-3.255.563 |
| Michael B. Atkins | Direttore | 12 Giugno 2025 A | · | 0 | 0 | $0 |
| Anil K. Singhal | Direttore | 12 Giugno 2025 A | · | 0 | 0 | $0 |
| Meeta Chatterjee | Direttore | 12 Giugno 2025 A | · | 0 | 0 | $0 |
| Alon Lazarus | Direttore | 12 Giugno 2025 A | 2.046.634 | 0 | 0 | $0 |
| Briggs Morrison | Direttore | 12 Giugno 2025 A | · | 0 | 0 | $0 |
| Michael A. Sherman | Direttore | 12 Giugno 2025 A | · | 0 | 0 | $0 |
| Derek Dirocco | Direttore | 24 Maggio 2024 A | · | 0 | 0 | $0 |
| Sakae Asanuma | Direttore | 04 Maggio 2021 C | 2.068.909 | 0 | 0 | $0 |
| Taiho Ventures LLC | Proprietario del 10% | 04 Maggio 2021 C | 2.068.909 | 0 | 0 | $0 |
| UPMC | Proprietario del 10% | 04 Maggio 2021 C | 1.097.756 | 0 | 0 | $0 |
| HBM Healthcare Investments (Cayman) Ltd. | Proprietario del 10% | 04 Maggio 2021 C | 625.995 | 0 | 0 | $0 |
| Steven H. Bloom | · | 01 Maggio 2025 A | · | 0 | 0 | $0 |
| Reid Leonard | · | 03 Gennaio 2023 A | 14.102 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 2 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
HOWL Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 8 analisti
COMPRA
Target mediano
$7.00
+654,2%
2 25,0%
Acquisto forte
4 50,0%
Compra
2 25,0%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
3 analisti · 2026-09-29Target medio $7.00 +654,2%
← Sotto tutti i target
Prezzo attuale $0.93
Basso$4.00
Media$7.00
Alto$10.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Lug 31, 2026